The TARGET-NASH Study Finds Prior Opioid Use Prevalent in NAFLD Patients
source: pixabay.com

The TARGET-NASH Study Finds Prior Opioid Use Prevalent in NAFLD Patients

Target RWE, an innovative health evidence solutions company based in Durham, North Carolina recently announced its current data from the study of nonalcoholic steatohepatitis (NASH) via PRNewswire. The study, entitled…

Continue Reading The TARGET-NASH Study Finds Prior Opioid Use Prevalent in NAFLD Patients
A New Mutation Causing Atypical Hemolytic Uremic Syndrome Has Been Discovered
source: pixabay.com

A New Mutation Causing Atypical Hemolytic Uremic Syndrome Has Been Discovered

Researchers have announced their identification of a specific gene mutation that can lead to atypical hemolytic uremic syndrome (aHUS). This gene is called DGKE and it is not a part of…

Continue Reading A New Mutation Causing Atypical Hemolytic Uremic Syndrome Has Been Discovered